Research Article

The Single Nucleotide Polymorphism PPARG2 Pro12Ala Affects Body Mass Index, Fat Mass, and Blood Pressure in Severely Obese Patients

Table 2

Demographic and clinical characteristics of participants according to the IL6 -174G >C (rs1800795) polymorphism.

VariablesTotal-174G >C polymorphism valueAdjusted value
GG ()C carriers ()

Clinical, anthropometrical, and body composition variables
Age (years)39.61 ± 8.6239.54 ± 7.9639.75 ± 9.810.889
Female/male, (%)126 (85.1)/22 (14.9)87 (69.0)/9 (40.9)39 (31.0)/13 (59.1)0.0110.022a
BMI (kg/m2)45.97 ± 6.3845.50 ± 6.2846.84 ± 6.490.2210.386b
Fat mass (kg)161.24 ± 12.9360.02 ± 11.9263.44 ± 14.450.1300.219b
Fat-free mass (kg)157.32 ± 9.0056.41 ± 8.0358.95 ± 10.410.1070.983b
SBP (mmHg)128.32 ± 17.92125.52 ± 16.08125.44 ± 14.460.9750.198c
DBP (mmHg)85.72 ± 13.6983.13 ± 11.2881.00 ± 9.720.2520.059c
Diabetes, (%)41 (27.7)27 (28.1)14 (26.9)0.8760.331d
Hypertension, (%)96 (4.8)62 (64.6)34 (65.4)0.9220.549c
Dyslipidemia, (%)117 (79.0)75 (71.1)42 (80.8)0.7060.319c
Log MVPA (min/week)244.52 ± 61.0450.77 ± 63.42§32.92 ± 55.11§0.1150.024e
Sedentary time (min/day)21176.82 ± 83.261170.42 ± 84.641188.71 ± 80.140.2160.230e

Biochemical parameters
Fasting glucose (mg/dL)110.14 ± 45.34109.48 ± 42.48111.35 ± 50.610.8120.609d
Fasting glucose range, (%)0.2300.174d
 <100 mg/dL87 (58.8)53 (60,9)34 (39.1)
 ≥100 mg/dL61 (41.2)43 (70.5)18 (29.5)
Fasting insulin (μU/mL)23.38 ± 14.7923.49 ± 15.6423.17 ± 13.220.9010.589d
HOMA-IR6.40 ± 4.906.45 ± 5.206.32 ± 4.330.8870.464d
GHb (%)6.29 ± 1.446.26 ± 1.396.34 ± 1.540.7550.792d
Total cholesterol (mg/dL)189.86 ± 37.98188.82 ± 41.36191.79 ± 31.060.6520.966c
HDL cholesterol (mg/dL)47.57 ± 11.3347.83 ± 11.6547.08 ± 10.810.7000.816c
LDL cholesterol (mg/dL)110.03 ± 35.40109.57 ± 38.68110.90 ± 28.500.8300.943c
Triglyceride (mg/dL)161.46 ± 78.11156.56 ± 73.11170.50 ± 12.010.3020.629c

Dietary intake
Energy (kcal)1699.44 ± 708.991652.17 ± 683.441786.71 ± 752.880.2720.906e
Proteins (%)17.36 ± 4.5916.97 ± 4.3218.08 ± 5.000.1630.177e
Carbohydrates (%)51.57 ± 8.7152.23 ± 8.6550.36 ± 8.780.2160.186e
Lipids (%)27.91 ± 6.5228.02 ± 6.2027.71 ± 7.130.7840.557e
 Saturated (%)8.43 ± 2.718.51 ± 2.698.29 ± 2.770.6300.459e
 Polyunsaturated (%)4.27 ± 1.664.13 ± 1.654.53 ± 1.660.1660.156e
 Monounsaturated (%)7.61 ± 2.617.35 ± 2.548.12 ± 2.700.1070.216e
P : S ratio0.56 ± 0.290.53 ± 0.300.59 ± 0.240.2720.056e
Cholesterol (g)219.39 ± 120.29208.14 ± 114.74240.16 ± 128.480.1220.434e
Fiber (g)15.17 ± 8.4315.14 ± 7.7215.22 ± 9.670.9520.424e

Data are presented as mean ± SD or (%). BMI: body mass index; HOMA-IR: homeostatic model assessment for insulin resistance; HbA1c: hemoglobin A1c; HDL: high-density lipoprotein; LDL: low-density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure; MVPA: moderate-to-vigorous physical activity; P : S ratio: polyunsaturated : saturated fatty acids ratio. Student’s t-test; chi-squared test. 1; 2. aAdjusted for age, BMI, sedentary time, and diabetes; badjusted for age, gender, sedentary time, and diabetes; cadjusted for age, gender, sedentary time, BMI, and diabetes; dadjusted for age, gender, sedentary time, and BMI; eadjusted for age, gender, BMI, and diabetes; §values were presented backtransformed.